The Listing of Money Trade Coin on Cryptocurrency Exchange and the Rising Promise of a New Era in Dubai
MONEY TRADE COIN, the new age cryptocurrency, dazzled its investors’ expectations by listing on NovaExchange. Immediate trading began post the launch by Money Trade Coin’s founder and CEO, Mr. Amit Lakhanpal and H.E. Sheikh Saqer Al Nahyan. The listing event held on September 17 at Burj Al Arab was witnessed by a list of 40 VIP businessmen including H.E. Sheikh Jumaa Al Maktoum, Mr. Faisal Almaazmi, his principal advisor and director of Greenland Capital Properties, Mr. Charles Said Kiwan founder of MVP Tech and Mr. Khaled Abdulla, Head of Communications MENA at Barclays PLC.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170921006013/en/
Amit Lakhanpal greets H.E. Sheikh Saqer Al Nahyan (Photo: AETOS Wire)
Money Trade Coin, the propagator of the “Cryptocurrency correct knowledge” launched a full-fledged product array: Cryptocurrency E-Academy and E-Portal. The trading platform offers the possibility to interexchange the different cryptocurrency coins such as BitCoin, Ethereum, Ripple, Moreno, and shall be trading all the 1,088 listed coins soon. It plans to go live on more than four exchanges: C6, Coinex, Poloniex and their own private exchange as its listing became a bold statement that investors demand has increasingly swept from traditional practices to digital currency as a secure alternative to safeguard wealth, eliminate costs, increase efficiency and flexibility, and save time while transacting.
Unique in its features “MONEY TRADE COIN” is a registered certified entity with a recognized identity, Mr. Amit Lakhanpal, a well-known businessman heading the Flintstone Group India and its IP is jointly owned by Bitcoin Global FZE, UAE and Money Trade Coin UK Ltd, licensed in: United Kingdom, Estonia, soon in Switzerland and India. Flintstone Technologies Private Limited, the Indian exchange platform, shall be launched on 19 October, 2017.
Acquiring “MONEY TRADE COIN” is limited to the transfer of existing Bitcoin, online gateway (credit/debit cards and PayPal), and traditional banking methods shall be established soon. The physical and digital card will be available in select countries. The value can be redeemed with various options such as online shopping, airline tickets among others. The currency will not only be limited to entertainment or ticketing but also to pay government taxes, utility bills and fines across GCC region, Asian and European countries as well.
Amit, published a book on Inter Cryptocurrency trading for Beginners and established a solid corporate sustainability program where 5% of the trading profits shall be given to the Charity Organizations of the UAE Government and 15% customized on welfare trusts sponsored run by the company.
Money Trade Coin eyed the Emirate of Dubai for its new expansion as the “Next Big Hit”, incorporation started supported by “Khalifa Bin Huwaidan Al Ketbi Advocates and Legal consultants” and Advocate Hashim Malik since Dubai, adopted the “Dubai Blockchain Strategy” for 2020 launched by H.H. Sheikh Hamdan Al Maktoum, under the directive of H.H. Sheikh Mohammed Bin Rashed Al Maktoum, the ruler of Dubai.
Money Trade Coin, ultra-secure wallet through multi-level verifications, is the world’s first fully secured Cryptocurrency, implementing the highest standards of compliance: KYC and AML keeping the records of all transactions for more than ten years. MONEY TRADE Initial Coin Offering (ICO) was held in 4 phases, 14 Million MT Coins were offered at each phase, the minimum subscription was capped at 1 MT Coin. As per the experts, Money Trade Coin is forecasted to exceed the value of USD 500 per coin this year across cryptocurrency exchanges.
*Source: AETOS Wire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170921006013/en/
Contact information
for Money Trade Coin
Kalpana Desai, +919833226461
kalpana@falcongroup.co.in
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new
MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release
The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin
IonQ Unanimously Appoints Peter Chapman as Next Chairman of the Board of Directors26.4.2024 13:30:00 CEST | Press release
IonQ (NYSE: IONQ), a leader in the quantum computing industry, announced today the appointment of Peter Chapman as its next Chairman of the Board and Harry You as the Lead Independent Director of the Board, effective at the close of IonQ’s upcoming Annual General Meeting on June 5, 2024. Both appointments were disclosed in a proxy statement issued on April 25, 2024. Peter Chapman has also been nominated for re-election as a Class III director at the meeting, and his chairmanship will take effect assuming he is re-elected. “Last quarter we were delighted to have appointed Robert Cardillo and Bill Scannell to our Board of Directors. In addition, the Board unanimously appointed Peter Chapman to serve as its next Chairman following the annual meeting given his half-decade worth of contributions to IonQ and his strong progress transitioning IonQ from an academic to a commercial company,” said Niccolo de Masi, Chairman of the Nominating & Corporate Governance Committee of IonQ’s Board. “Unde